PBIO Stock UPDATES Pressure Biosciences (PBIO) 0.3000 09/13/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Pressure Biosciences (PBIO) 0.3000 $PBIO

Pressure BioSciences, Inc. to Present at Rodman & Renshaw and SeeThruEquity NY Investment Conferences
PR Newswire - Wed Sep 10, 9:56AM CDT
Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company" today announced that Mr. Richard T. Schumacher, President and CEO, will present a corporate overview and business update at the Rodman and Renshaw ("Rodman" and SeeThruEquity ("STE" Investment Conferences this week in New York City. Mr. Schumacher's presentation at Rodman is scheduled for Wednesday, September 10 at 12:05pm in the Palace Hotel. Mr. Schumacher's presentation at STE is scheduled for Thursday, September 11 at 9:00am at the Convene Times Square.

Pressure BioSciences Inc. ("PBI" (OTCQB: PBIO) Exclusive Interview for Interlinked's Investment News Channel, InterlinkedTV at FSXinterlinked Investment Conference
PRWeb - Thu Aug 28, 5:02AM CDT
Pressure BioSciences Inc., ("PBI" (OTCQB: PBIO) was one of the presenting companies at the recent FSXinterlinked Investment Conference held at the Four Seasons Hotel in Westlake Village, California.

Pressure BioSciences, Inc. ("PBI" (OTCQB: PBIO) to Discuss Second Quarter 2014 Financial Results and Provide a Business Update
PRWeb - Wed Aug 13, 6:05PM CDT
Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" and the "Company" today announced that the Company will host a teleconference to discuss its Second Quarter 2014 financial results and to provide a business update. Anyone interested may listen to the teleconference either by telephone (live) or through a replay by telephone or on the Company's website.

Pressure BioSciences Inc. to Host Second Quarter 2014 Earnings Conference Call and Webcast Live on Thursday, August 14, 2014
ACCESSWIRE - Wed Aug 13, 3:06PM CDT
SOUTH EASTON, MA / ACCESSWIRE / August 13, 2014 / Pressure BioSciences Inc. (OTCQB: PBIO) will host a conference call and live webcast to discuss the results of the second quarter 2014, to be held Thursday, August 14, 2014 at 4:30 PM Eastern Time.

Pressure BioSciences, Inc. to Discuss Second Quarter 2014 Financial Results and Provide a Business Update
PR Newswire - Wed Aug 13, 7:23AM CDT
Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" and the "Company" today announced that the Company will host a teleconference to discuss its Second Quarter 2014 financial results and to provide a business update. Anyone interested may listen to the teleconference either by telephone (live) or through a replay by telephone or on the Company's website.

Pressure BioSciences to Develop Front-end Sample Preparation for Parabase Genomics' Targeted Next Generation Sequencing Testing Platform
PR Newswire - Tue Jul 22, 6:11AM CDT
Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company" and Parabase Genomics ("Parabase" , (together "the companies" , today announced they have entered into a strategic research and development agreement (the "collaboration" . Under the terms of the collaboration, PBI will develop a front-end, sample preparation method for Parabase's enhanced neonatal molecular diagnostics and newborn confirmatory testing process. The sample preparation method will be based on PBI's patented and enabling Pressure Cycling Technology ("PCT" platform.

Pressure BioSciences, Inc. (OTCQB: PBIO) to Present at the FSXinterlinked Investment Conference
PRWeb - Tue Jul 15, 6:08AM CDT
Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company" today announced that Mr. Richard T. Schumacher, President and CEO, will present a corporate overview and business update at the FSXinterlinked Investment Conference being held from July 30th to August 2nd, 2014 at the Four Seasons, Westlake Village, CA.

Pressure BioSciences Engages IssuWorks in Strategic Advisory Role
PR Newswire - Thu Jun 26, 8:53AM CDT
Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company" today announced the engagement of IssuWorks to provide strategic advisory services to the Company's board of directors and management team. IssuWorks is the first conflict-free, company-aligned investment bank using technology and services to dramatically improve investor targeting, securities marketing, and distribution in public and private markets. Pressure BioSciences has retained IssuWorks and their management team to review strategic and financing alternatives, including the possible spin-off of vertical market applications into new, stand alone businesses.

Launch of Novel, High Throughput PCT-based Barozyme HT48 System "Very Successful" Says Pressure BioSciences
PR Newswire - Mon Jun 23, 7:16AM CDT
On June 12, 2014, Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company" announced the planned launch of their much anticipated, high throughput pressure cycling technology ("PCT" -based system at the 62nd conference of the American Society for Mass Spectrometry ("ASMS" . The ASMS Conference was held June 15-19, 2014 in Baltimore, MD.

Transformative Impact and Adoption of Pressure BioSciences' PCT Platform Prominently Highlighted Throughout Week at Major Scientific Conference
PR Newswire - Thu Jun 19, 10:46AM CDT
Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company" today announced that scientists from six separate research groups presented data at the 62nd Annual Conference of the American Society for Mass Spectrometry ("ASMS" being held from June 15-19, 2014 in Baltimore, MD. Study results indicated that utilizing the Company's patented pressure cycling technology ("PCT" platform in the preparation of samples for analysis resulted in critically enabling quality and/or improved time or cost efficiency of test results. These studies were conducted by scientists from ETH Zurich and the University of Zurich ("ETH Zurich" ; Laboratory Corporation of America ("Lab Corp" ; the Food and Drug Administration ("FDA" ; the University of Minnesota ("UMN" , Mayo Clinic, and the Karolinska Instituet; Northeastern University ("NEU" ; and the Baltimore VA Medical Center ("BVAMC" , SAIC-Frederick, National Cancer Institute, and the Veteran's Health Administration.

Pressure BioSciences to Launch Its Much Anticipated High Throughput PCT-based Instrument System (the Barozyme HT48) at the Upcoming ASMS Annual Conference
PR Newswire - Thu Jun 12, 11:43AM CDT
Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company" today announced it will launch its high throughput, PCT-based Barozyme HT48 instrument system for the enhanced preparation of proteins for mass spectrometry analysis at the upcoming American Society for Mass Spectrometry ("ASMS" Annual Conference on Mass Spectrometry and Allied Topics. The ASMS Conference is being held June 15-19, 2014 in Baltimore, Maryland.

Pressure BioSciences, Inc. Reports Strong Fourth Quarter and Fiscal Year 2013 Financial Results
PR Newswire - Tue Apr 01, 9:42AM CDT
Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company" today announced financial results for the three-month period and fiscal year ended December 31, 2013 and provided a business update.

Pressure BioSciences, Inc. to Discuss Fourth Quarter and Fiscal Year 2013 Financial Results and Provide a Business Update
PR Newswire - Mon Mar 31, 8:37AM CDT
Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" and the "Company" today announced that the Company will host a teleconference to discuss its Fourth Quarter and Fiscal Year 2013 financial results and to provide a business update. Anyone interested may listen to the teleconference either by telephone (live) or through a replay on the Company's website. The teleconference information is provided below:

Pressure BioSciences Inc. Exclusive Interview for the Interlinked Investment News Channel on InterlinkedTV
PRWeb - Fri Mar 21, 3:37PM CDT
Pressure BioSciences Inc. was one of the presenting companies interviewed at the recent FSXinterlinked Investment Conference, held at the Ritz Carlton in Dallas, Texas.

Pressure BioSciences Announces the Release and Initial Sale of the Barocycler HUB880, a "First-in-Kind" Ultra High Pressure Bench-top Instrument System
PR Newswire - Wed Mar 19, 9:23AM CDT
Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company" today announced the commercial release of the Barocycler HUB880, the newest addition to the Company's growing line of high-pressure instrument systems. The Company also announced the sale (and shipment) of its first HUB880 system to Dr. Wayne Hubbell of the University of California Los Angeles (UCLA). PBI plans to showcase the HUB880 at the upcoming U.S. Human Proteome Organization's 10th Annual Conference to be held at the Westin-Seattle (WA), April 6-9, 2014.

Pressure BioSciences, Inc. to Present at the NIBA Florida Investment Conference
PR Newswire - Thu Feb 27, 8:43AM CST
Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company" today announced that Mr. Richard T. Schumacher, President and CEO, will present a corporate overview and business update at the Florida Investment Conference of the National Investment Banking Association ("NIBA" . The NIBA Investment Conference is being held from February 26-28 at the Riverside Hotel in Ft. Lauderdale, Florida. Mr. Schumacher is scheduled to present today (February 27th) at 2:50 pm EST in the Himarshee Ballroom.

TriStar Wellness Solutions® Obtains New Patent for HemCon's Chitosan Technology in Japan
PR Newswire - Wed Feb 12, 7:30AM CST
TriStar Wellness Solutions®, Inc. (OTCQB: TWSI), a health and wellness company that targets opportunities in the self-care and professional marketplace, has recently been awarded a new patent that supports our emerging status in the Japanese medical/dental markets. Patent application number 2008-537698 has received final approval for issuance to HemCon Medical Technologies® Inc., a wholly owned subsidiary of TriStar Wellness Solutions, and is specific to HemCon's chitosan-based dental sponges for the Japanese market.

Pressure BioSciences Introducing New Technology for Its Pressure Cycling Platform
PRWeb - Thu Jan 16, 5:14AM CST
Pressure BioSciences, Inc. (OTCQB: PBIO) record sales in the third-quarter have given the company a bright future. Analysts are even more optimistic about 2014 because the company is going to introduce a breakthrough technology for use in its pressure cycling platform that uses an HT system.




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Daqo New Energy Faces Key Investor Meeting in December

Updated Category News Views 88

Spotlight on December's Agenda for Daqo Shareholders Who'd have thought we'd be looking at another year end with the same burning energy interests? Daqo New Energy Corp. (NYSE: DQ) is setting up for its annual general meeting (AGM) dated December 10, 2026. Mark your calendars, because these gatherings can be more than just straightforward affairs; sometimes they reveal...

Continue Reading
Bacterial Breakthrough in Cancer Therapy: Game Changer?

Updated Category News Views 7

Blurring Lines Between Bugs and Biotech Well, wouldn't you know it, the eggheads over at Jeonbuk National University in South Korea are at it again, pushing the boundaries of what these little bacterial buggers can do. This time, they’ve had a crack at cancer therapy, using engineered Salmonella to pack a double punch against breast cancer in mice. Now, if that ain't...

Continue Reading
IQSTEL's Nine-Month Revenue Hits $313M, Growth Impresses

Updated Category News Views 41

Pushing Through With Persistence Well, well, well, here we are, talking about IQSTEL Inc. (NASDAQ: IQST) slinging some serious numbers—not the kind you can ignore at your breakfast table. The company pulled in a whopping $313 million in revenue over the first nine months of 2026. That’s a bump up by 34.5% from last year’s $232.7 million. What’s behind the magic...

Continue Reading
AdMaven's Mave AI: Revolutionizing Campaign Management

Updated Category News Views 19

Taking the Tedious Out of Advertising You've got to love it when technology actually makes life easier, rather than more complicated. AdMaven's latest fancy toy, the AI assistant Mave, is promising just that. It's designed to take the heavy lifting off advertisers' shoulders, especially the day-to-day grind of tweaking ad settings and monitoring performance. If you've...

Continue Reading
Dawson Struggles With Q3 Losses Despite Growth Prospects

Updated Category News Views 42

Profit and loss dance around like a jittery stock, and Dawson Geophysical is feeling the heat this third quarter. Numbers are in, and we’re seeing a net loss of $5.2 million, translating to $0.17 per share—ouch. Not to mention a negative Adjusted EBITDA of $2 million. Compared to last year's hopes, that's a serious belly flop. Revenue Down, Hopes Up In a fetching...

Continue Reading
DoGo Power Revamps Energy for Remote Indonesian Isle

Updated Category News Views 114

Bringing Light to Pagerungan Kecil Island These days, if you wander into the fishing communities of Pagerungan Kecil Island, the buzz isn't just from the daily catch. Residents are talking about power, and not the kind you get from a generator spluttering along—I'm talking about a brand-new energy storage system that’s turning the lights on in ways these folks have...

Continue Reading
Roche Delivers Endotrophin Assay to Nordic Bioscience Lab

Updated Category News Views 52

Roche Opens New Frontier in Diagnostic Biomarkers Get ready to chew on this: Roche Diagnostics is bringing something new to Nordic Bioscience's CLIA lab. They're offering up their Endotrophin research prototype assay on the cobas® e801 Analyzer. Now, what does this mean for the scientific world? Well, it might just shake things up for those battling cardiovascular and...

Continue Reading
DarioHealth's New Research Tackles Healthcare Cost Estimation

Updated Category News Views 91

Unpacking Dario's Bold Surgical Strike at ISPOR Europe Alright, folks, DarioHealth is shaking up the stage with their new methodology that could very well carve a new path in how we size up digital healthcare savings. Presented at ISPOR Europe 2026, Dario's tactic bypasses the sluggish wait on medical claims data, instead offering an evidence-driven peek at potential...

Continue Reading
Fapon's MEDICA 2026 Bid: Game-Changer or Same Old?

Updated Category News Views 147

Fapon's Ambitious Pitch at MEDICA: A Real Deal? MEDICA 2026 sees Fapon stepping up, laden with flashy promises and hardened expertise. Set up in Düsseldorf, these folks are pushing their Local Manufacturing Solutions harder than a door-to-door vacuum seller. The main pitch? Bolstering local IVD production with their comprehensive tech transfer services. How many outfits...

Continue Reading
ICCSD in Beijing: AI and Culture's Future Explored

Updated Category News Views 136

AI's Intersection with Culture in the Spotlight Imagine a room full of people hammering out the future of AI and culture—it starts to feel like a melting pot for the mind. That was the scene in Beijing when the ICCSD Advisory Committee congregated on October 26, 2026. With experts pooling from four different countries, there was no shortage of fireworks. They hashed out...

Continue Reading

Top 5 Most Recently Viewed Articles

Moatable, Inc. Concludes the Tender Offer for Class A Shares

Updated Category News Views 139

Moatable, Inc. Completes Tender Offer for Class A Shares Moatable, Inc. (Pink Limited Market: MTBLY), a premier US-based SaaS company, has announced the successful completion of its fixed price tender offer. The company aimed to repurchase an impressive 225 million Class A ordinary shares. Each share has a par value of $0.001, and they can also be represented by American...

Continue Reading
Armstrong World Industries' Q4 Earnings: What Investors Need

Updated Category News Views 164

Armstrong World Industries Q4 Earnings Report Let’s dive right into this latest earnings report from Armstrong World Indus (NYSE:AWI) that just hit the streets. Released on February 24, 2026, bright and early, it’s got both good news and some not-so-great tidbits that every investor should chew on. Honestly, missing earnings estimates by a margin like -3.59% just...

Continue Reading
Batteries Plus Enhances Partnership for Educational Safety Needs

Updated Category News Views 254

Batteries Plus Enhances Partnership for Educational Safety Needs From Campus Fleets to Classroom Security, Local Teams Support Operational Readiness for Schools and Universities Nationwide Batteries Plus is deepening its partnerships with K-12 districts, colleges, and universities by supplying a broad range of comprehensive battery, lighting, and security system support....

Continue Reading
Exciting Developments in Houston: The RO Project Advances

Updated Category News Views 453

Transwestern Launches Next Phase of The RO Development Transwestern, a prominent commercial real estate firm headquartered in Houston, has taken a monumental step forward by breaking ground on the next phase of The RO. This innovative project aims to redefine the River Oaks neighborhood, representing a significant addition to the area that harmonizes various aspects of...

Continue Reading
BMO Financial Group Plans Large Share Repurchase Initiative

Updated Category News Views 95

BMO Financial Group's Strategic Share Buyback Program Bank of Montreal (TSX:BMO)(NYSE:BMO) has announced an ambitious plan to repurchase up to 20 million common shares through a normal course issuer bid. This initiative is designed to strengthen the bank's capital structure and reflects its confidence in its business fundamentals. Details of the Share Repurchase Plan The...

Continue Reading